Marked Expansion of CD11c+CD8+ T-Cells in Melanoma-bearing Mice Induced by Anti-4-1BB Monoclonal Antibody |
Ju, Seong-A
(Department of Biological Sciences and Immunomodulation Research Center, University of Ulsan)
Park, Sang-Min (Department of Biological Sciences and Immunomodulation Research Center, University of Ulsan) Lee, Sang-Chul (Department of Biological Sciences and Immunomodulation Research Center, University of Ulsan) Kwon, Byoung S. (Department of Biological Sciences and Immunomodulation Research Center, University of Ulsan) Kim, Byung-Sam (Department of Biological Sciences and Immunomodulation Research Center, University of Ulsan) |
1 | Alleva, D. G.., Burger, C. J., and Elgert, K. D. (1994) Tumorinduced regulation of suppressor macrophage nitric oxid and TNF-alpha production. Role of tumor-derived IL-10, TGFbeta, and prostaglandin E2. J. Immunol. 153, 1674−1686 |
2 | Kobayashi, M., Kobayashi, H., Pollard, R. B., and Suzuki, F. (1998) A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J. Immunol. 160, 5869-5873 |
3 | Maeda, H. and Shiraishi, A. (1996) TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. 156, 73-78 |
4 | Seo, S. K., Choi, J. H., Kim, Y. H., Kang, W. J., Park, H. Y., et al. (2004) 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med. 10, 1088-1094 |
5 | Vinay, D. S. and Kwon, B.S. (1998) Role of 4-1BB in immune responses. Semin. Immunol. 10, 481-489 |
6 | McAdam, A. J., Pulaski, B. A., Harkins, S. S., Hutter, E. K., Lord, E. M., et al. (1995) Synergistic effects of co-expression of the Th1-cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells. Int. J. Cancer. 61, 628-634 DOI ScienceOn |
7 | Yu, P., lee, Y., Liu, W., Krausz, T., Chong, A., et al. (2005) Intratumor depletion of cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. JEM 201, 779-791 DOI ScienceOn |
8 | Jang, Y. J., Nam, S. Y., Kim, M. S., Seong, R. H., Park, Y. S., et al. (2002) Simultaneous expression of allogenic class II MHC and B7.1 (CD80) molecules in A20 B-lymphoma cell line enhances tumor immunogenicity. Mol. Cells 13, 130-136 |
9 | Li, Q., Carr, A., Ito, F., Teitz-Tennenbaum, S., and Chang, A. E. (2003) Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy. Cancer Res. 63, 2546-2552 |
10 | Park, E. K., Soh, B. Y., Jang, Y. S., Park, J. H., and Chung, G. H. (2001) Immune induction and modulation in mice following immunization with DNA encoding F protein of respiratory syncytial virus. Mol. Cells 12, 50-56 |
11 | Taraban, V. Y., Rowley, T. F., O'Brien, L., Chan, H. T., Haswell, L. E., et al. (2002) Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses. Eur. J. Immunol. 32, 3617-3627 DOI ScienceOn |
12 | Boon, T., De Plaen, E., Lurquin, C., Van den Eynde, B., and van der Bruggen, P. (1992) Identification of tumor rejection antigens recognized by T lymphocytes. Cancer Surv. 13, 23-37 |
13 | Kim, Y. H., Seo, S. K., Choi, B. K., Kang, W. J., Kim, C. H., et al. (2005) 4-1BB costimulation enhances HSV-1-specific T cell responses by the induction of T cells. Cell. Immunol. 238, 76-86 |
14 | Pulendran, B., Lingappa, J., Kennedy, M. K., Smith, J., Teepe, M., et al. (1997) Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 159, 2222-2231 |
15 | Weber, J. S. and Rosenberg, S. A. (1998) Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro. Cancer Res. 48, 5818-5824 |
16 | Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281, 65-78 DOI |
17 | Jang, I. K., Lee, Z. H., Kim, H. H., Hill, J. M., Kim J. D., et al. (2001) A Novel leucine-rich repeat protein (LRR-1): Potential involvement in 4-1BB-mediated signal transduction. Mol. Cells 12, 304-312 |
18 | Chang, S. K., Park, B., Shin, J., Ahn, J. H., Kim, I. H., et al. (2002) Proto-oncogene PML enhances antigen presentation by MHC class I molecules in human lung cancer cells. Mol. Cells 14, 130-135 |
19 | Ju, S. A., Lee, S. C., Kwon, T. H., Heo, S. K., Park, S. M., et al. (2005) Immunity to melanoma mediated by 4-1BB is associated with enhanced activity of tumour-infiltrating lymphocytes. Immunol. Cell Biol. 83, 344-351 DOI ScienceOn |
20 | Melero, I., Shuford, W. W., Newby, S. A., Aruffo, A., Ledbetter, J. A., et al. (1997) Monoclonal antibodies against the 4-1BB T-cell activation molecule can eradicate established tumors. Nat. Med. 3, 682-685 DOI ScienceOn |
21 | Wilcox, R. A., Flies D. B., Zhu, G.., Johnson, A. J., Tamada, K., et al. (2002) Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J. Clin. Invest. 109, 651-659 DOI |
22 | Ghosh, P., Komschlies, K. L., Cippitelli, M., Longo, D. L., Subleski, J., et al. (1995) Gradual loss of T-helper 1 populations in spleens of mice during progressive tumor growth. J. Nat. Cancer Inst. 87, 1478-1483 DOI ScienceOn |
23 | Miller, R. E., Jones, J., Le, T., Whitmore, J., Boiani, N., et al. (2002) 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner. J. Immunol. 169, 1792-800 |
24 | Kiertscher, S. M., Luo, J., Dubinett, S. M., and Roth, M. D. (2000) Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J. Immunol. 164, 1269-1276 DOI |
25 | Huleatt, J. W. and Lefrancois, L. (1995) Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and T cells in vivo. J. Immunol. 154, 5684-5693 |